Connor, Clark & Lunn Investment Management Ltd. - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 82 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$44,700
-87.8%
37,881
-22.2%
0.00%
-100.0%
Q3 2022$366,000
+302.2%
48,668
+238.6%
0.00%
+100.0%
Q2 2022$91,000
-52.6%
14,374
-37.9%
0.00%0.0%
Q1 2022$192,000
+88.2%
23,146
+85.0%
0.00%0.0%
Q3 2020$102,000
-86.3%
12,509
-83.9%
0.00%
-80.0%
Q2 2020$747,000
+31.7%
77,796
-6.8%
0.01%0.0%
Q1 2020$567,000
+165.0%
83,450
+480.5%
0.01%
+400.0%
Q4 2019$214,00014,3750.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Simplify Asset Management Inc. 2,700,000$823,5000.09%
683 Capital Management, LLC 2,650,000$808,2500.06%
GSA CAPITAL PARTNERS LLP 355,867$1090.01%
RBF Capital, LLC 391,265$119,3360.01%
UBS OCONNOR LLC 393,975$120,1620.00%
XTX Topco Ltd 15,597$4,7570.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 106,700$32,5440.00%
AMERIPRISE FINANCIAL INC 8,592,471$2,620,7040.00%
DRW Securities, LLC 120,365$370.00%
DFPG INVESTMENTS, LLC 32,430$10,8960.00%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders